Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT OF ERNST & YOUNG LLP - AVEO PHARMACEUTICALS, INC. | d264862dex231.htm |
| EX-21.1 - SUBSIDIARIES - AVEO PHARMACEUTICALS, INC. | d264862dex211.htm |
| EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC. | d264862dex321.htm |
| EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC. | d264862dex312.htm |
| EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC. | d264862dex311.htm |
| EX-10.8 - FORM OF RESTRICTED STOCK AGREEMENT - AVEO PHARMACEUTICALS, INC. | d264862dex108.htm |
| EX-10.25 - AMENDMENT NO. 1 TO LOAN & SECURITY AGREEMENT - AVEO PHARMACEUTICALS, INC. | d264862dex1025.htm |
| EX-10.29 - FIRST AMENDMENT TO SUBLEASE - AVEO PHARMACEUTICALS, INC. | d264862dex1029.htm |
| EX-10.23 - EXTENSION LETTER AMENDMENT - AVEO PHARMACEUTICALS, INC. | d264862dex1023.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AVEO PHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - AVEO PHARMACEUTICALS, INC. | d264862d10k.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of AVEO Pharmaceuticals, Inc. (the “Company”) for the fiscal year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, David Johnston, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that, to his knowledge on the date hereof:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 30, 2012
| /s/ David B. Johnston |
| David B. Johnston |
| Chief Financial Officer |